Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 12.84% |
| Q2 2025 | 34.94% |
| Q1 2025 | -85.97% |
| Q4 2024 | -23.50% |
| Q3 2024 | 8.92% |
| Q2 2024 | 2715.38% |
| Q1 2024 | -97.48% |
| Q4 2023 | 22.74% |
| Q3 2023 | 27.00% |
| Q2 2023 | 81.02% |
| Q1 2023 | -28.48% |
| Q4 2022 | -0.16% |
| Q3 2022 | -24.48% |
| Q2 2022 | 0.06% |
| Q1 2022 | -18.07% |
| Q4 2021 | -11.07% |
| Q3 2021 | -5.86% |
| Q2 2021 | 5.55% |
| Q1 2021 | -24.80% |
| Q4 2020 | -2.76% |
| Q3 2020 | -16.31% |
| Q2 2020 | 16.78% |
| Q1 2020 | -6.20% |
| Q4 2019 | 10.90% |
| Q3 2019 | 33.86% |
| Q2 2019 | 124.90% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | -100.00% |
| Q2 2017 | 766.46% |
| Q1 2017 | -80.92% |
| Q4 2016 | -99.48% |
| Q3 2016 | 1057.49% |
| Q2 2016 | 13.83% |
| Q1 2016 | 21.19% |
| Q4 2015 | 42.29% |